These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


730 related items for PubMed ID: 22939904

  • 1. In vitro-expanded CD4(+)CD25(high)Foxp3(+) regulatory T cells controls corneal allograft rejection.
    Guo X, Jie Y, Ren D, Zeng H, Zhang Y, He Y, Pan Z.
    Hum Immunol; 2012 Nov; 73(11):1061-7. PubMed ID: 22939904
    [Abstract] [Full Text] [Related]

  • 2. Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.
    Xia G, He J, Zhang Z, Leventhal JR.
    Transplantation; 2006 Dec 27; 82(12):1749-55. PubMed ID: 17198271
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
    Su H, Ye DQ, Wang BL, Fang XH, Chen J, Wang Q, Li WX, Zhang N.
    Br J Dermatol; 2008 Jun 27; 158(6):1197-209. PubMed ID: 18410422
    [Abstract] [Full Text] [Related]

  • 4. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK, Seavey CN, Horvath KA, Mohiuddin MM.
    Xenotransplantation; 2012 Jun 27; 19(2):102-11. PubMed ID: 22497512
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation.
    Siemasko KF, Gao J, Calder VL, Hanna R, Calonge M, Pflugfelder SC, Niederkorn JY, Stern ME.
    Invest Ophthalmol Vis Sci; 2008 Dec 27; 49(12):5434-40. PubMed ID: 18658093
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF, Gao J, Zhang D, Wang ZH, Zhu JY.
    Chin Med J (Engl); 2010 Apr 05; 123(7):942-8. PubMed ID: 20497692
    [Abstract] [Full Text] [Related]

  • 10. The role of Foxp3+ regulatory T cells in liver transplant tolerance.
    Li W, Carper K, Zheng XX, Kuhr CS, Reyes JD, Liang Y, Perkins DL, Thomson AW, Perkins JD.
    Transplant Proc; 2006 Dec 05; 38(10):3205-6. PubMed ID: 17175223
    [Abstract] [Full Text] [Related]

  • 11. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
    Wang S, Jiang J, Guan Q, Lan Z, Wang H, Nguan CY, Jevnikar AM, Du C.
    Transpl Immunol; 2008 May 05; 19(2):93-102. PubMed ID: 18503884
    [Abstract] [Full Text] [Related]

  • 12. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY, Wang XH, Zhang F, Li XC, Yao AH, Yu Y, Lv L, Li GQ.
    Surgery; 2007 Jul 05; 142(1):67-73. PubMed ID: 17630002
    [Abstract] [Full Text] [Related]

  • 13. Tolerogenic dendritic cells suppress murine corneal allograft rejection by modulating CD28/CTLA-4 expression on regulatory T cells.
    Yan F, Cai L, Hui Y, Chen S, Meng H, Huang Z.
    Cell Biol Int; 2014 Jul 05; 38(7):835-48. PubMed ID: 24604878
    [Abstract] [Full Text] [Related]

  • 14. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M, Piccirillo CA.
    J Leukoc Biol; 2007 Aug 05; 82(2):335-46. PubMed ID: 17475784
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
    Qu Y, Zhang B, Zhao L, Liu G, Ma H, Rao E, Zeng C, Zhao Y.
    Transpl Immunol; 2007 Apr 05; 17(3):153-61. PubMed ID: 17331841
    [Abstract] [Full Text] [Related]

  • 18. Ex vivo-expanded natural CD4+CD25+ regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts.
    Xia G, He J, Leventhal JR.
    Am J Transplant; 2008 Feb 05; 8(2):298-306. PubMed ID: 18190656
    [Abstract] [Full Text] [Related]

  • 19. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F, Chen Z, Xu S, Cai M, Wu M, Li H, Chen X.
    Surgery; 2009 Jun 05; 145(6):663-74. PubMed ID: 19486771
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of alanyl-aminopeptidase on CD4+CD25+ regulatory T-cells enhances expression of FoxP3 and TGF-beta1 and ameliorates acute colitis in mice.
    Bank U, Tadje J, Täger M, Wolke C, Bukowska A, Ittenson A, Reinhold D, Helmuth M, Ansorge S, Shakespeare A, Vieth M, Malfertheiner P, Naumann M, Lendeckel U.
    Int J Mol Med; 2007 Oct 05; 20(4):483-92. PubMed ID: 17786278
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 37.